Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Head and Neck Neoplasms × Methadone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Pain, Postoperative 1 Pain 1 Malignant Female Reproductive System Neoplasm 1 Ileus 1 Head and Neck Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Cancer Pain 1 Agnosia 1

Interventions

Cisplatin 4 Fluorouracil 3 Norepinephrine 2 Fentanyl 2 Docetaxel 2 Cetuximab 2 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 technetium Tc 99m nanocolloid 1 nimotuzumab 1 dopexamine 1 Venlafaxine Hydrochloride 1 Tobacco Use Cessation Devices 1 Taste 1 Sugars 1 Saline Solution 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pregabalin 1 Polymerase Chain Reaction 1 Oral Hygiene 1 Neck Dissection 1 Morphine 1 Mitomycin 1 Mirtazapine 1 Methadone 1 Levobupivacaine 1 Gene Expression Profiling 1 Gastrostomy 1 Gabapentin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01317589 2015-07-16

310111-4

Maastricht University Medical Center

Phase 4 Completed

Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡